Screener
Mirum Pharmaceuticals, Inc. MIRM Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s free cash flow?
- Mirum Pharmaceuticals, Inc. (MIRM) reported free cash flow of -$44.28M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s free cash flow decreased by 471.6% year-over-year, from $11.91M to -$44.28M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s free cash flow has grown at a -25.5% compound annual growth rate (CAGR), from -$132.78M to $54.87M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Mirum Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude